Harnessing heterocyclic diversity to combat microbial resistance: Current advances and future perspectives

Triazole derivatives, as up-and-coming candidates for antibacterial and antifungal agents, possess structural diversity that offers extensive possibilities for addressing microbial infection challenges. By hybridizing with various heterocyclic structures such as pyrimidine, indole, coumarin, and thiazole, these compounds can act on different targets of bacteria and fungi, exhibiting rich antimicrobial activities. Their mechanisms of action cover multiple key physiological processes: disrupting the integrity of bacterial cell membranes and cell walls, blocking protein synthesis pathways, interfering with the metabolic cycles of nucleic acids and folic acid, etc. The combination of different heterocyclic structures with the triazole ring can enhance specific binding to microbial targets by regulating the spatial conformation and electron distribution of the molecule, thereby significantly improving antimicrobial efficacy. Given the increasingly severe problem of bacterial drug resistance, triazole derivatives play an important role in the development of new antimicrobial drugs, providing key ideas for breaking through existing therapeutic bottlenecks.